ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07850063. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-centre, Randomised, Double-blind, Placebo-controlled, Phase IIIb Trial to Evaluate the Effect of Survodutide on Cardiac Structure and Function of Participants With Overweight or Obesity and Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD); (ELEVATE-LIVER)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is for adults aged 18 years and older who have a type of fatty liver disease called metabolic dysfunction-associated steatotic liver disease (MASLD). People can take part if their body mass index (BMI) is 27 kg/m² or higher, and they have certain heart and blood vessel risk factors. The purpose of this study is to find out how a medicine called survodutide affects heart structure and function in people with MASLD. Participants are put into 2 groups randomly, which means by chance. One group gets survodutide as an injection under the skin of the abdomen once a week. The other group gets placebo as an injection once a week. Placebo looks like survodutide but does not contain any medicine. The first injection is given at the study site. Later injections are usually given by the participants themselves at home using pre-filled syringes. Participants and doctors do not know who is getting survodutide or placebo. Participants are in the study for up to 1.5 years. During this time, they visit the study site about 14 times and have about 4 phone calls with the study staff. At some of the visits, doctors use ultrasound scans to check the heart. The results are compared between the 2 groups to see if survodutide helps improve the health of the heart. The study staff also regularly check participants' health and take note of any health problems.
Study identification
- NCT ID
- NCT07850063
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 600 participants
Conditions and interventions
Interventions
- Survodutide Combination Product
- Placebo matching survodutide Combination Product
Combination Product
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 25, 2026 (Estimated)
- Primary completion
- Apr 29, 2029 (Estimated)
- Completion
- Apr 29, 2029 (Estimated)
- Last update posted
- Nov 18, 2026
2026 – 2029
United States locations
- U.S. sites
- 28
- U.S. states
- 16
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Clinical Trials - Flagstaff Liver Clinic | Flagstaff | Arizona | 86001 | — |
| The Institute for Liver Health II DBA Arizona Clinical Trials | Peoria | Arizona | 85381 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| Fomat Medical Research | Oxnard | California | 93030 | — |
| California Liver Research Institute | Pasadena | California | 91105 | — |
| Interventional Cardiology Medical Group | West Hills | California | 91307 | — |
| Advanced Research Institute | Denver | Colorado | 80218 | — |
| Rocky Mountain Gastroenterology | Lakewood | Colorado | 80228 | — |
| Florida Research Institute | Lakewood Rch | Florida | 34211 | — |
| Covenant Metabolic Specialists, LLC - University Park | University Park | Florida | 34201 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Kansas Medical Clinic PA | Topeka | Kansas | 66606 | — |
| Capital Digestive Care | Chevy Chase | Maryland | 20815 | — |
| Woodholme Gastroenterology Associates | Glen Burnie | Maryland | 21061 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Huron Gastroenterology Associates | Ypsilanti | Michigan | 48197 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Southwest Gastroenterology Associates, P.C. | Albuquerque | New Mexico | 87109 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Coastal Research Institute, LLC | Fayetteville | North Carolina | 28304 | — |
| Moses H. Cone Memorial Hospital | Greensboro | North Carolina | 27401 | — |
| Piedmont HealthCare, PA | Statesville | North Carolina | 28625 | — |
| Oregon Health & Sciences University | Portland | Oregon | 97239 | — |
| Palmetto Clinical Research | Summerville | South Carolina | 29485 | — |
| Internal Medicine and Pediatric Associates of Bristol, PC | Bristol | Tennessee | 37620 | — |
| Methodist Dallas Medical Center | Dallas | Texas | 75203 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Advanced Research Institute | Sandy City | Utah | 84070 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07850063, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 18, 2026 · Synced Nov 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.